Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12590598rdf:typepubmed:Citationlld:pubmed
pubmed-article:12590598lifeskim:mentionsumls-concept:C0936012lld:lifeskim
pubmed-article:12590598lifeskim:mentionsumls-concept:C1710236lld:lifeskim
pubmed-article:12590598lifeskim:mentionsumls-concept:C0386636lld:lifeskim
pubmed-article:12590598lifeskim:mentionsumls-concept:C0060447lld:lifeskim
pubmed-article:12590598pubmed:issue7lld:pubmed
pubmed-article:12590598pubmed:dateCreated2003-2-19lld:pubmed
pubmed-article:12590598pubmed:abstractTextUDP-galactopyranose mutase is a flavoprotein which catalyses the interconversion of UDP-galactopyranose and UDP-galactofuranose. The enzyme is of interest because it provides the activated biosynthetic precursor of galactofuranose, a key cell wall component of many bacterial pathogens. The reaction mechanism of this mutase is intriguing because the anomeric oxygen forms a glycosidic bond, which means that the reaction must proceed by a novel mechanism involving ring breakage and closure. The structure of the enzyme is known, but the mechanism, although speculated on, is not resolved. The overall reaction is electrically neutral but a crypto-redox reaction is suggested by the requirement that the flavin must adopt the reduced form for activity. Herein we report a thermodynamic analysis of the enzyme's flavin cofactor with the objective of defining the system and setting parameters for possible reaction schemes. The analysis shows that the neutral semiquinone (FADH(*)) is stabilized in the presence of substrate and the fully reduced flavin is the anionic FADH(-) rather than the neutral FADH(2). The anionic FADH(-) has the potential to act as a rapid 1-electron donor/acceptor without being slowed by a coupled proton transfer and is therefore an ideal crypto-redox cofactor.lld:pubmed
pubmed-article:12590598pubmed:languageenglld:pubmed
pubmed-article:12590598pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12590598pubmed:citationSubsetIMlld:pubmed
pubmed-article:12590598pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12590598pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12590598pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12590598pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12590598pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12590598pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12590598pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12590598pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12590598pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12590598pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12590598pubmed:statusMEDLINElld:pubmed
pubmed-article:12590598pubmed:monthFeblld:pubmed
pubmed-article:12590598pubmed:issn0006-2960lld:pubmed
pubmed-article:12590598pubmed:authorpubmed-author:NaismithJames...lld:pubmed
pubmed-article:12590598pubmed:authorpubmed-author:WhitfieldChri...lld:pubmed
pubmed-article:12590598pubmed:authorpubmed-author:ChapmanStephe...lld:pubmed
pubmed-article:12590598pubmed:authorpubmed-author:DaffSimonSlld:pubmed
pubmed-article:12590598pubmed:authorpubmed-author:IngledewW...lld:pubmed
pubmed-article:12590598pubmed:authorpubmed-author:FullertonStep...lld:pubmed
pubmed-article:12590598pubmed:authorpubmed-author:SandersDavid...lld:pubmed
pubmed-article:12590598pubmed:issnTypePrintlld:pubmed
pubmed-article:12590598pubmed:day25lld:pubmed
pubmed-article:12590598pubmed:volume42lld:pubmed
pubmed-article:12590598pubmed:ownerNLMlld:pubmed
pubmed-article:12590598pubmed:authorsCompleteYlld:pubmed
pubmed-article:12590598pubmed:pagination2104-9lld:pubmed
pubmed-article:12590598pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:12590598pubmed:meshHeadingpubmed-meshheading:12590598...lld:pubmed
pubmed-article:12590598pubmed:meshHeadingpubmed-meshheading:12590598...lld:pubmed
pubmed-article:12590598pubmed:meshHeadingpubmed-meshheading:12590598...lld:pubmed
pubmed-article:12590598pubmed:meshHeadingpubmed-meshheading:12590598...lld:pubmed
pubmed-article:12590598pubmed:meshHeadingpubmed-meshheading:12590598...lld:pubmed
pubmed-article:12590598pubmed:meshHeadingpubmed-meshheading:12590598...lld:pubmed
pubmed-article:12590598pubmed:meshHeadingpubmed-meshheading:12590598...lld:pubmed
pubmed-article:12590598pubmed:meshHeadingpubmed-meshheading:12590598...lld:pubmed
pubmed-article:12590598pubmed:meshHeadingpubmed-meshheading:12590598...lld:pubmed
pubmed-article:12590598pubmed:meshHeadingpubmed-meshheading:12590598...lld:pubmed
pubmed-article:12590598pubmed:meshHeadingpubmed-meshheading:12590598...lld:pubmed
pubmed-article:12590598pubmed:meshHeadingpubmed-meshheading:12590598...lld:pubmed
pubmed-article:12590598pubmed:meshHeadingpubmed-meshheading:12590598...lld:pubmed
pubmed-article:12590598pubmed:meshHeadingpubmed-meshheading:12590598...lld:pubmed
pubmed-article:12590598pubmed:meshHeadingpubmed-meshheading:12590598...lld:pubmed
pubmed-article:12590598pubmed:year2003lld:pubmed
pubmed-article:12590598pubmed:articleTitlePotentiometric analysis of UDP-galactopyranose mutase: stabilization of the flavosemiquinone by substrate.lld:pubmed
pubmed-article:12590598pubmed:affiliationCentre for Biomolecular Sciences, The University, St. Andrews KY16 9ST, UK.lld:pubmed
pubmed-article:12590598pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12590598pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12590598lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12590598lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12590598lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12590598lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12590598lld:pubmed